AAAAAA

   
Results: 1-12 |
Results: 12

Authors: YEH KC DEUTSCH PJ HADDIX H HESNEY M HOAGLAND V JU WD JUSTICE SJ OSBORNE B STERRETT AT STONE JA WOOLF E WALDMAN S
Citation: Kc. Yeh et al., SINGLE-DOSE PHARMACOKINETICS OF INDINAVIR AND THE EFFECT OF FOOD (VOL42, PG 336, 1998), Antimicrobial agents and chemotherapy, 42(5), 1998, pp. 1308-1308

Authors: YEH KC DEUTSCH PJ HADDIX H HESNEY M HOAGLAND V JU WD JUSTICE SJ OSBORNE B STERRETT AT STONE JA WOOLF E WALDMAN S
Citation: Kc. Yeh et al., SINGLE-DOSE PHARMACOKINETICS OF INDINAVIR AND THE EFFECT OF FOOD, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 332-338

Authors: MUELLER BU SLEASMAN J NELSON RP SMITH S DEUTSCH PJ JU W STEINBERG SM BALIS FM JAROSINSKI PF BROUWERS P MISTRY G WINCHELL G ZWERSKI S SEI SZ WOOD LV ZEICHNER S PIZZO PA
Citation: Bu. Mueller et al., A PHASE I II STUDY OF THE PROTEASE INHIBITOR INDINAVIR IN CHILDREN WITH HIV-INFECTION/, Pediatrics (Evanston), 102(1), 1998, pp. 101-109

Authors: HUFF JR VACCA JP DORSEY BD EMINI EA CONDRA JH SCHLEIF WA MASSARI FE DEUTSCH PJ CHODAKEWITZ J KUO LC CHEN Z
Citation: Jr. Huff et al., CRIXIVAN(R) - A POTENT INHIBITOR OF HIV-1 PROTEASE IN-VIVO, The FASEB journal, 11(9), 1997, pp. 23-23

Authors: BALANI SK WOOLF EJ HOAGLAND VL STURGILL MG DEUTSCH PJ YEH KC LIN JH
Citation: Sk. Balani et al., DISPOSITION OF INDINAVIR, A POTENT HIV-1 PROTEASE INHIBITOR, AFTER ANORAL DOSE IN HUMANS, Drug metabolism and disposition, 24(12), 1996, pp. 1389-1394

Authors: CONDRA JH HOLDER DJ SCHLEIF WA BLAHY OM DANOVICH RM GABRYELSKI LJ GRAHAM DJ LAIRD D QUINTERO JC RHODES A ROBBINS HL ROTH E SHIVAPRAKASH M YANG T CHODAKEWITZ JA DEUTSCH PJ LEAVITT RY MASSARI FE MELLORS JW SQUIRES KE STEIGBIGEL RT TEPPLER H EMINI EA
Citation: Jh. Condra et al., GENETIC CORRELATES OF IN-VIVO VIRAL RESISTANCE TO INDINAVIR, A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITOR, Journal of virology, 70(12), 1996, pp. 8270-8276

Authors: GOLDBERG MR LO MW DEUTSCH PJ WILSON SE MCWILLIAMS EJ MCCREA JB
Citation: Mr. Goldberg et al., PHENOBARBITAL MINIMALLY ALTERS PLASMA-CONCENTRATIONS OF LOSARTAN AND ITS ACTIVE METABOLITE E-3174, Clinical pharmacology and therapeutics, 59(3), 1996, pp. 268-274

Authors: CONDRA JH SCHLEIF WA BLAHY OM GABRYELSKI LJ GRAHAM DJ QUINTERO JC RHODES A ROBBINS HL ROTH E SHIVAPRAKASH M TITUS D YANG T ZHANG J CHODAKEWITZ JA DEUTSCH PJ EMINI EA
Citation: Jh. Condra et al., DYNAMICS OF ACQUIRED HIV-1 CLINICAL RESISTANCE TO THE PROTEASE INHIBITOR MK-639, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 72-72

Authors: CONDRA JH SCHLEIF WA BLAHY OM GABRYELSKI LJ GRAHAM DJ QUINTERO JC RHODES A ROBBINS HL ROTH E SHIVAPRAKASH M TITUS D YANG T ZHANG J DEUTSCH PJ SQUIRES KE EMINI EA
Citation: Jh. Condra et al., EVIDENCE FOR THE EXISTENCE OF LONG-LIVED GENETIC RESERVOIRS OF HIV-1 IN INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 82-82

Authors: KONG ANT TOMASKO L WALDMAN SA OSBORNE B DEUTSCH PJ GOLDBERG MR BJORNSSON TD
Citation: Ant. Kong et al., LOSARTAN DOES NOT AFFECT THE PHARMACOKINETICS AND PHARMACODYNAMICS OFWARFARIN, Journal of clinical pharmacology, 35(10), 1995, pp. 1008-1015

Authors: CONDRA JH SCHLEIF WA BLAHY OM GABRYELSKI LJ GRAHAM DJ QUINTERO JC RHODES A ROBBINS HL ROTH E SHIVAPRAKASH M TITUS D YANG T TEPPLER H SQUIRES KE DEUTSCH PJ EMINI EA
Citation: Jh. Condra et al., IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS, Nature, 374(6522), 1995, pp. 569-571

Authors: DEUTSCH PJ SCHADLOW VC BARZILAI N
Citation: Pj. Deutsch et al., 38-AMINO ACID FORM OF PITUITARY ADENYLATE-CYCLASE ACTIVATING PEPTIDE INDUCES PROCESS OUTGROWTH IN HUMAN NEUROBLASTOMA-CELLS, Journal of neuroscience research, 35(3), 1993, pp. 312-320
Risultati: 1-12 |